Inositol phosphate metabolism and nitric-oxide synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 2, 2000, Pages 698-703

  Parenti, Astrid ^a   Filippi, Sandra ^a   Amerini, Sandra ^a   Granger, Harris J ^b   Fazzini, Alessandro ^a   Ledda, Fabrizio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL PHOSPHATE; NEBIVOLOL; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; NONHUMAN; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; BENZOPYRANS; CATTLE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ESTRENES; ETHANOLAMINES; INDOMETHACIN; INOSITOL PHOSPHATES; MESENTERIC ARTERIES; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; PYRROLIDINONES; RATS; RATS, WISTAR; THAPSIGARGIN; TIME FACTORS; VASODILATOR AGENTS; VEINS;

EID: 0033971823     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Amerini S, Filippi S, Parenti A, Ziche M and Ledda F (1996) Thapsigargin inhibits the response to acetylcholine and substance P but does not interfere with the response to endothelium-independent agents. J Cardiovasc Pharmacol 28:82-88.
2. Berdeaux A (1993) Nitric oxide: A ubiquitous messenger. Fund Clin Pharmacol 7:401-411.
3. Bleasdale JE, Thakur NR, Gremban RS, Bundy GL, Fitzpatrick FA, Smith RJ and Bunting S (1990) Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther 255:756-768.
4. Bolton TB, Lang RJ and Takewaki T (1984) Mechanism of action of noradrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery. J Physiol 351:549-572.
5. Bowman AJ, Chen CPLH and Ford GA (1994) Nitric oxide mediated venodilator effects of nebivolol. Br J Clin Pharmacol 38:199-204.
6. Busse R, Fichtner H and Luckhoff A (1988) Hyperpolarization and increased free calcium in acetylcholine-stimulated endothelial cells. Am J Physiol 255:H965-H969.
7. Cockcroft JR, Chowienczyk PJ, Brett SE, Chen CP, Dupont AG, Van Nueten L, Wooding SJ and Ritter JM (1995) Nebivolol vasodilates human forearm vasculature: Evidence for an L-arginine/NO-dependent mechanism. J Pharmacol Exp Ther 274:1067-1071.
8. Criscione L, Mueller K and Prescott MF (1984) Endothelial cell loss enhances the pressor response in resistance vessels. J Hypertension 2 (Suppl):441-444.
9. Dolor RJ, Hurwitz LM, Mirza Z, Strauss HC and Whorton AR (1992) Regulation of extracellular calcium entry in endothelial cells: Role of intracellular calcium pool. Am J Physiol 262:C171-C181.
10. Furchgott RF and Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond) 288:373-376.
11. Gao Y, Nagao T, Bond RA, Janssens WJ and Vanhoutte PM (1991) Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol 17:964-969.
12. Ghigo D, Arese M, Todde R, Vecchi A, Silvagno F, Costamagna C, Dong QG, Alessio M, Heller R, Soldi R, Trucco F, Garbarino G, Pescarmona G, Mantovani A, Bussolino F and Bosia A (1995) Middle T antigen-transformed endothelial cells exhibit an increased activity of nitric oxide synthase. J Exp Med 181:9-19.
13. Grierson JP and Meldolesi J (1995) Calcium homeostasis in mouse fibroblast cells: Affected by U-73122, a putative phospholipase C β-blocker, via multiple mechanisms. Br J Pharmacol 115:11-14.
14. Guard S and Watson SP (1991) Tachykinin receptor types: Classification and membrane signalling mechanisms. Neurochem Int 18:149-165.
15. Janssens WJ, Van De Water A, Xhonneux R, Reneman RS, Van Nueten JM and Janssen PAJ (1989) Nebivolol is devoid of intrinsic sympathomimetic activity. Eur J Pharmacol 159:89-96.
16. Janasens WJ, Xhonneux R and Janssen PAJ (1991) Animal pharmacology of nebivolol. Drug Investig 3:13-24.
17. Jin W, Lo TM, Loh HH and Thayer SA (1994) U73122 inhibits phospholipase C-dependent calcium mobilization in neuronal cells. Brain Res 642:237-243.
18. Jones SVP (1993) Muscarinic receptor subtypes: Modulation of ion channels. Life Sci 52:457-464.
19. ++ pool in vascular smooth muscles. J Pharmacol Exp Ther 258:1105-1113.
20. Luckhoff A, Pohl U, Mulsch A and Busse R (1988) Differential role of extra-and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br J Pharmacol 95:189-196.
21. Lytton J, Westlin M and Hanley MR (1991) Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Mol Chem 266:17067-17071.
22. Macarthur H, Hecker M, Busse R and Vane JR (1993) Selective inhibition of agonist-induced but not shear-dependent release of endothelial autacoids by thapsigargin. Br J Pharmacol 108:100-105.
23. Mantelli L, Amerini S and Ledda F (1995) Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol 25:595-602.
24. Parenti A, Morbidelli L, Cui X-L, Douglas JG, Hood JD, Granger HJ, Ledda F and Ziehe M (1998) Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 273:4220-4226.
25. Schelling ME, Meininger CJ, Hawker JR and Granger HJ (1988) Venular endotheliai cells from bovine heart. Am J Physiol 254:H1211-H1217.
26. 2+-ATPase. Proc Natl Acad Sci USA 87:2466-2470.
27. 9-bradykinin and bradykinin. J Pharmacol Exp Ther 264:930-937.
28. 1-adrenergic antagonist. J Cardiovasc Pharmacol 11:552-563.
29. Van De Water A, Xhonneux R, Reneman RS and Janssen PA (1988b) Cardiovascular effects of nebivolol and its enantiomers - A comparison with those of atenolol. Eur J Pharmacol 156:95-103.
30. Xhonneux R, Wouters L, Reneman RS and Janssen PA (1990) The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of d-enantiomer. Eur J Pharmacol 181:261-265.
31. 2+ oscillations in response to cholecystokinin and carbachol but not to JMV-180 in rat pancreatic acinar cells. J Biol Chem 20:13830-13835.
32. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P and Ledda F (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036-2044.
33. Ziehe M, Zawieja D, Hester K and Granger H (1993) Calcium entry, mobilization, and extrusion in postcapillary venular endothelium exposed to bradykinin. Am J Physiol 265:H569-H580.